Pediatric Oncology: Diagnosis And Prognosis Communication

Pediatric Oncology: Diagnosis And Prognosis Communication Overview When a child is diagnosed with cancer, it is an incredibly difficult situation for everyone in the family, and the parents especially have a hard time understanding the complicated details of the diagnosis and outcome. They usually want doctors to be honest and transparent, though

Carfilzomib Therapy in Pediatric Acute Lymphoblastic Leukemia

Carfilzomib Therapy in Pediatric Acute Lymphoblastic Leukemia Overview In this study, the safety and tolerability of a combination of carfilzomib and vincristine, dexamethasone, asparaginase, and daunorubicin (VXLD) were assessed in children with relapsed and/or refractory acute lymphoblastic leukemia (ALL). ALL is the most common cancer diagnosed in childhood and survival for patients

nusinersen therapy for pediatric spinal muscular atrophy

nusinersen therapy for pediatric spinal muscular atrophy Study Background  Spinal muscular atrophy (SMA) is an inherited motor neuron disease caused by the degeneration of anterior horn cells of the spinal cord and brainstem. SMA primarily affects babies and young children and has an incidence of 1:10,000. It is caused by a homozygous

pediatric liver transplantation: a new biological abdominal wall

pediatric liver transplantation: a new biological abdominal wall Study Background  Liver transplantation (LT) is the only definitive treatment for children with advanced liver disease. Pediatric liver transplantation  has evolved significantly over the past few decades, with excellent short-term and long-term survival rates. However, graft matching challenges, especially size-matched donors, remain. Also, in

pediatric leukemia patients utilizing levofloxacin

pediatric leukemia patients utilizing levofloxacin STUDY BACKGROUND Bacterial infection-related morbidity and mortality are high in children treated for acute myeloid leukemia (AML) and relapsed acute lymphoblastic leukemia (rALL). Bacteremia not only contributes to mortality but also prolongs hospitalization, delays chemotherapy, decreases the quality of life, and requires the administration of costly and

Pediatric Oncology: Diagnosis And Prognosis Communication